StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) operating KPIs

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)

Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%

Thermo Fisher Scientific tăng trưởng doanh thu hữu cơ — Laboratory Products & Biopharma Services (%)

IR Financial Reconciliation Package (Business Segment Information) & SEC MD&A

QuarterlyAnnual
Latest, Q3 2026
10.0%
Period ended Sep 30, 2026
Change on a year earlier
+7.0 pts
3.0% in Q3 2025
History
15 quarters
Since Q1 2023
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTăng trưởng doanh thu hữu cơ — Laboratory Products & Biopharma Services (%)Year on yearSource
Q3 2026Sep 30, 202610.0%+7.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20265.0%+2.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 20264.0%+5.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20255.0%+1.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20253.0%+3.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 20253.0%+4.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 2025-1.0%0.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20244.0%+9.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20240.0%-1.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 2024-1.0%-6.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 2024-1.0%-8.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 2023-5.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20231.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 20235.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 20237.0%–Q4 & FY2024 Reconciliation of Financial Information ↗

Breakdown

What makes up tăng trưởng doanh thu hữu cơ — laboratory products & biopharma services

Cite this data

StockData. (2026). Thermo Fisher Scientific Tăng trưởng doanh thu hữu cơ — Laboratory Products & Biopharma Services (%), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/org_growth_pct_lpbs

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.